FINANCIAL CONSULATE, INC

Position in MRK — Merck & Co., Inc.

CIK 1624510 HUNT VALLEY, MD

Position in MRK

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$976,471

+$67,320 QoQ

Shares Held

7,599

+0.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.75%

of 13F equity value

Holder Rank

#2,138

of 3,769 holders

Holding Since

Mar 2020

17 quarters on record

Voting authority Sole 49% Shared 0% None 51%

Healthcare · as of Jun 30, 2026

FINANCIAL CONSULATE, INC holds $4,839,565 across 15 Drug Manufacturers - General names. MRK ranks #2 (20.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,232	$1,477,697
2	MRK	Merck & Co., Inc. This page	7,599	$976,471
3	JNJ	Johnson & Johnson	3,667	$931,307
4	ABBV	AbbVie Inc.	3,167	$796,943
5	AZN	Astrazeneca PLC	870	$164,969
6	AMGN	Amgen Inc	445	$161,143
7	BMY	Bristol Myers Squibb Co	1,572	$90,578
8	NVS	Novartis AG	515	$80,710

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$976,471	7,599	+0.5%	Shares	Sole	2026-07-23
2026-03-31	$909,151	7,558	-13.2%	Shares	Sole	2026-04-21
2025-12-31	$916,077	8,703	-1.8%	Shares	Sole	2026-01-22
2025-09-30	$744,207	8,867	+54.8%	Shares	Sole	2025-10-21
2023-03-31	$609,508	5,729	-30.4%	Shares	Other	2023-04-17
2022-12-31	$913,895	8,237	-2.4%	Shares	Other	2023-01-11
2022-09-30	$726,594	8,437	-4.3%	Shares	Other	2022-10-20
2022-06-30	$804,119	8,820	-4.4%	Shares	Other	2022-07-19
2022-03-31	$756,829	9,224	+11.8%	Shares	Other	2022-04-28
2021-12-31	$632,356	8,251	+0.3%	Shares	Sole	2022-02-07
2021-09-30	$618,155	8,230	+0.1%	Shares	Other	2021-10-19
2021-06-30	$639,580	8,224	-5.3%	Shares	Other	2021-07-22
2021-03-31	$669,758	8,688	-0.1%	Shares	Other	2021-04-19
2020-12-31	$711,577	8,699	-4.4%	Shares	Other	2021-01-29
2020-09-30	$754,762	9,099	-3.8%	Shares	Other	2020-10-20
2020-06-30	$731,078	9,454	-3.3%	Shares	Other	2020-07-22
2020-03-31	$752,165	9,776	—	Shares	Other	2020-04-29
No filing history on record for this holder in this stock.